Better Therapeutics Inc
OTC:BTTX

Watchlist Manager
Better Therapeutics Inc Logo
Better Therapeutics Inc
OTC:BTTX
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 5k USD

Profitability Summary

Better Therapeutics Inc's profitability score is 38/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

38/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

38/100
Profitability
Score
38/100
Profitability
Score

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Better Therapeutics Inc

Revenue
0 USD
Operating Expenses
-29.6m USD
Operating Income
-29.6m USD
Other Expenses
-2m USD
Net Income
-31.6m USD

Margins Comparison
Better Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Better Therapeutics Inc
OTC:BTTX
5k USD N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
48B USD
28%
27%
US
Cerner Corp
LSE:0R00
31.3B USD
13%
10%
AU
Pro Medicus Ltd
ASX:PME
29.5B AUD
75%
52%
US
Doximity Inc
NYSE:DOCS
12.5B USD
40%
40%
JP
M3 Inc
TSE:2413
1.5T JPY
21%
13%
US
Waystar Holding Corp
NASDAQ:WAY
6.8B USD
21%
9%
SE
Sectra AB
STO:SECT B
59.6B SEK
-19%
27%
US
Heartflow Inc
NASDAQ:HTFL
3.2B USD N/A N/A
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
255.2B INR N/A N/A
US
Vocera Communications Inc
F:V00
2.4B EUR
0%
-4%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Better Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Better Therapeutics Inc
OTC:BTTX
5k USD
2 351%
-162%
-355%
-916%
US
Veeva Systems Inc
NYSE:VEEV
48B USD
14%
11%
14%
43%
US
Cerner Corp
LSE:0R00
31.3B USD
14%
8%
12%
10%
AU
Pro Medicus Ltd
ASX:PME
29.5B AUD
52%
39%
64%
101%
US
Doximity Inc
NYSE:DOCS
12.5B USD
24%
21%
24%
59%
JP
M3 Inc
TSE:2413
1.5T JPY
11%
8%
13%
13%
US
Waystar Holding Corp
NASDAQ:WAY
6.8B USD
3%
2%
5%
3%
SE
Sectra AB
STO:SECT B
59.6B SEK
32%
17%
-21%
-13%
US
Heartflow Inc
NASDAQ:HTFL
3.2B USD N/A N/A N/A N/A
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
255.2B INR N/A N/A N/A N/A
US
Vocera Communications Inc
F:V00
2.4B EUR
-5%
-2%
0%
0%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less